✦ LIBER ✦

Comparison of outcome measures from a trial of Mycophenolate mofetil in myasthenia gravis

✍ Scribed by Gil I. Wolfe; Richard J. Barohn; Donald B. Sanders; Michel P. McDermott

Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 83 KB
Volume: 38
Category: Article
ISSN: 0148-639X
DOI: 10.1002/mus.21142

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of myasthenia gravis with myco

Treatment of myasthenia gravis with mycophenolate mofetil: A case report

✍ Matthew N. Meriggioli; Julie Rowin 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 87 KB 👁 3 views

We report a patient with myasthenia gravis (MG) who had marked clinical benefit in response to treatment with mycophenolate mofetil as documented by serial quantitative measures of strength and muscle fatigue. Our patient had experienced either adverse side effects or a suboptimal response to the us

Randomized, controlled trial of intraven

Randomized, controlled trial of intravenous immunoglobulin in myasthenia gravis

✍ Gil I. Wolfe; Richard J. Barohn; Barbara M. Foster; Carlayne E. Jackson; John T. 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB

## Abstract We initiated a randomized, double‐blinded, placebo‐controlled trial of intravenous immunoglobulin (IVIG) treatment in myasthenia gravis (MG). Patients received IVIG 2 gm/kg at induction and 1 gm/kg after 3 weeks vs. 5% albumin placebo. The primary efficacy measurement was the change in

Comparison of rheumatoid arthritis clini

Comparison of rheumatoid arthritis clinical trial outcome measures: A simulation study

✍ Jennifer J. Anderson; James A. Bolognese; David T. Felson 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB 👁 2 views

Outcome of plasmapheresis in myasthenia

Outcome of plasmapheresis in myasthenia gravis: Delayed therapy is not favorable

✍ Aditya Mandawat; Anant Mandawat; Henry J. Kaminski; Zaid A. Shaker; Aws A. Alawi 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 93 KB

## Abstract __Introduction:__ The purpose of this study was to compare the in‐hospital mortality and complication rates after early and delayed initiation of plasma exchange (PLEX) in patients with myasthenia gravis (MG). __Methods:__ Our cohort was identified from the Nationwide Inpatient Sample d

Evaluation of renal function in liver tr

Evaluation of renal function in liver transplant recipients receiving daclizumab (Zenapax), mycophenolate mofetil, and a delayed, low-dose tacrolimus regimen vs. a standard-dose tacrolimus and mycophenolate mofetil regimen: A multicenter randomized clinical trial

✍ Eric M. Yoshida; Paul J. Marotta; Paul D. Greig; Norman M. Kneteman; Denis Marle 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 111 KB

Posttransplant chronic renal failure, secondary to calcineurin inhibitor agents, is emerging as a major problem in liver transplantation. We report a randomized clinical trial comparing daclizumab, delayed low-dose tacrolimus (target trough level 4-8 ng/mL, starting day 4-6), Investigational Arm (n

Comparison of three rating scales as out

Comparison of three rating scales as outcome measures for treatment trials of depression in Alzheimer disease: findings from DIADS

✍ Lawrence S. Mayer; R. Curt Bay; Antonios Politis; Martin Steinberg; Cynthia Stee 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB 👁 1 views

## Abstract ## Context Major depression affects about 25% of patients with Alzheimer's disease (AD) and has serious adverse consequences for patients as well as caregivers. Studies of treatments for depression in AD, like most treatment studies, depend on the ability of the scales used to measure